VDR and triple-A syndrome: Oral treatment with calcitriol reduced angiotensin II (AngII)-induced dissecting AAA formation in apolipoprotein E deficient (ApoE-/-) mice with marked increase in VDR-retinoid X receptor (RXR)-α interaction in the aortas of calcitriol-treated mice.